AD’s clinical diversity (e.g., posterior cortical atrophy, logopenic variant primary progressive aphasia) contrasts with its uniform pathology (amyloid plaques, tau tangles), creating challenges in linking imaging findings to varied clinical presentations (Jellinger, 2022). The gene discussed is MAPT; the disease is posterior cortical atrophy.